This was an investigator-initiated, prospective, open-label, randomized, controlled study conducted at Hiroshima University Hospital between April 2011 and March 2013. We studied 30 patients with ...

Organic nitrates have been used widely as antianginal drugs for many years, and have an established role in the management of patients with anginal syndromes, including stable angina on effort and ...

Angina pectoris is a debilitating indication of thepresence of ischemic heart disease that affects millionsof Americans. Although a number of pharmacologictreatments are available, the annual numberof ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels -- thereby reducing the risk of heart attack or ...

More recent animal studies also show that SCS gives rise to catecholamine release in the myocardium, which may contribute to the development of protective changes, similar to those occurring in ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

BEGINNING with the preparation of theobromine sodium salicylate in 1894 1 and erythrol tetra-nitrate in 1895, 2 many new measures have been advocated for the prevention of attacks of angina pectoris.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

This Week’s Question: My understanding is that angina is not as serious as heart disease. Is this true? Angina pectoris--or simply angina--is the medical term for chest pain or discomfort usually ...

The FDA has given its okay to Espero Pharmaceutical’s Gonitro that is indicated to provide or prevent acute relief to patients who suffer an attack of angina pectoris. The nitroglycerin sublingual ...